Biolexis Therapeutics

Biolexis Therapeutics Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Biolexis Therapeutics, Pharmaceutical Company, 3900 N. Traverse Mountain Boulevard , Suite 200, Lehi, UT.

Biolexis Therapeutics is a biotech company committed to accelerating the development of novel targeted therapeutics for cancers and other diseases by joining our proprietary data with the power of machine learning and artificial intelligence.

Alzheimer’s disease has long been defined by cognitive decline. But that way of thinking is changing.In this episode of ...
03/24/2026

Alzheimer’s disease has long been defined by cognitive decline. But that way of thinking is changing.

In this episode of the Good Medicine Podcast, Dr. David Bearss sits down with Dr. Brendon Boot from S2N to discuss how the field of Alzheimer’s research has evolved from focusing on symptoms to understanding the underlying changes in the brain.

They explore how this shift is influencing regulators, the importance of earlier intervention, and how new therapies could change the way we approach neurodegenerative disease.

Dr. Boot also shares how S2N is using naturally occurring Alzheimer’s in dogs as a model for clinical development, and why this approach may help accelerate progress toward human therapies.

If early results translate to humans, even partially, this work has the potential to significantly impact how Alzheimer’s is treated in the future.

Topics covered include:

• The shift from symptom-based to biology-based understanding of Alzheimer’s
• Why earlier intervention may be critical for treatment success
• Using naturally occurring disease models to advance clinical research

Alzheimer’s disease has long been defined by cognitive decline. But that way of thinking is changing.In this episode of the Good Medicine Podcast, Dr. David ...

Heart disease remains the leading cause of death worldwide, yet many of the biggest risk factors are preventable.In this...
03/17/2026

Heart disease remains the leading cause of death worldwide, yet many of the biggest risk factors are preventable.

In this episode of the Good Medicine Podcast, Dr. David Bearss sits down with Dr. Troy Badger from CardioStrong to talk about what actually improves cardiovascular health and what people often get wrong when trying to optimize their health.

They discuss the importance of lifestyle and fitness for reducing cardiovascular risk, the overwhelming amount of health advice circulating on social media, and why simple habits often matter more than complicated protocols.

Dr. Badger shares practical insight from working with patients and athletes on improving long-term health and performance.

Topics covered include:

• Why lifestyle and exercise remain the most powerful tools for heart health
• Navigating misinformation in online health advice
• The importance of simplicity in maintaining long-term health

Heart disease remains the leading cause of death worldwide, yet many of the biggest risk factors are preventable.In this episode of the Good Medicine Podcast...

This week on the Good Medicine Podcast, Dr. David Bearss sits down with Alex Wallberg from SPARC Health to talk about bu...
03/10/2026

This week on the Good Medicine Podcast, Dr. David Bearss sits down with Alex Wallberg from SPARC Health to talk about building healthcare startups that actually improve patient outcomes.

SPARC Health focuses on helping technical founders navigate the complex world of healthcare innovation by pairing them with experienced mentors, operators, and capital providers who can guide companies through the challenges of building in life sciences and health technology.

Alex shares how SPARC works with founders to translate promising ideas into real companies, and why mentorship, community, and strategic support are essential for success in healthcare innovation.

The conversation also explores what separates great founders from the rest. Alex emphasizes that the best entrepreneurs keep patients at the center of their mission, while Dr. Bearss notes that when founders focus primarily on money rather than impact, it is often a warning sign.

Finally, Alex reflects on the strength of Utah’s life sciences community and why collaboration between entrepreneurs, investors, and operators has become one of the region’s biggest advantages.

This week on the Good Medicine Podcast, Dr. David Bearss sits down with Alex Wallberg from SPARC Health to talk about building healthcare startups that actua...

This week on the Good Medicine Podcast, Dr. David Bearss sits down with Dr. Evan Unger, physician-scientist, serial biot...
03/03/2026

This week on the Good Medicine Podcast, Dr. David Bearss sits down with Dr. Evan Unger, physician-scientist, serial biotech entrepreneur, and pioneer in therapeutic oxygen delivery technologies.

Dr. Unger has spent decades working at the intersection of medicine, physics, and innovation. His work has focused on developing technologies that improve how oxygen is delivered to tissues in critical conditions such as cancer and heart attack. Tumor hypoxia, a state where parts of a tumor are deprived of adequate oxygen, has long been recognized as a major barrier to effective radiation therapy. Hypoxic tumors are more resistant to treatment, which can limit outcomes. Dr. Unger discusses why this problem has persisted since it was first described in the 1950s and why he believes his current work may represent one of the first meaningful approaches to reversing tumor hypoxia.

The conversation also explores the realities of being an inventor and biotech founder. Dr. Unger reflects on how having too many ideas can become a liability, and why focus, regulatory strategy, market opportunity, and disciplined value creation are essential for translating innovation into impact.

Finally, he shares why he remains driven by the possibility that new approaches to oxygen delivery could fundamentally transform treatment for heart attack, still the leading cause of death in the United States. This episode is about persistence, disciplined innovation, and pursuing breakthroughs that could change outcomes at scale.

This week on the Good Medicine Podcast, Dr. David Bearss sits down with Dr. Evan Unger, physician-scientist, serial biotech entrepreneur, and pioneer in ther...

This week on the Good Medicine Podcast, Dr. David Bearss sits down with Olympic gold medalist Peter Vidmar to talk about...
02/25/2026

This week on the Good Medicine Podcast, Dr. David Bearss sits down with Olympic gold medalist Peter Vidmar to talk about excellence, discipline, and the lifelong impact of exercise.

Peter reflects on his journey to Olympic gold, the influence of a coach who emphasized fundamentals above everything else, and how mastering the basics accelerated his growth. He shares how his love for gymnastics began at a young age and why he never cared whether his peers understood his passion.

The conversation also explores Peter’s work with the “Ready, Set, Gold” program, where Olympians partnered with schools to inspire young people to improve their physical fitness. He discusses the powerful connection between physical activity, mental health, and long-term well-being.

From elite competition to everyday fitness, this episode is about consistency, discipline, and finding movement that works for you.
://www.youtube.com/watch?v=MoqqazE7XRs

This week on the Good Medicine Podcast, Dr. David Bearss sits down with Olympic gold medalist Peter Vidmar to talk about excellence, discipline, and the life...

This week on the Good Medicine Podcast, Dr. David Bearss sits down with Dr. Myles Greenberg, President and CEO of InCard...
02/17/2026

This week on the Good Medicine Podcast, Dr. David Bearss sits down with Dr. Myles Greenberg, President and CEO of InCarda Therapeutics, to explore the non-traditional path from practicing physician to life sciences executive.

With more than 25 years of experience across clinical medicine, venture capital, entrepreneurship, and executive leadership, Dr. Greenberg shares how operating under uncertainty in the emergency room directly prepared him for leading companies through high-stakes decision making.

They discuss the realities of clinical trial ex*****on, the challenges of recruiting patients in acute care settings, and why innovation in medicine remains one of the most demanding yet rewarding fields to work in.

This episode is about resilience, adaptability, and the drive to solve unmet patient needs at scale.

This week on the Good Medicine Podcast, Dr. David Bearss sits down with Dr. Myles Greenberg, President and CEO of InCarda Therapeutics, to explore the non-tr...

In this episode of the Good Medicine Podcast, Dr. David Bearss sits down with Dr. Jim Hotaling and Dr. Brad Cairns from ...
02/04/2026

In this episode of the Good Medicine Podcast, Dr. David Bearss sits down with Dr. Jim Hotaling and Dr. Brad Cairns from Paterna Biosciences to talk about a new way of thinking about male infertility.

Dr. Brad Cairns explains that in many cases, stem cells themselves are not the root of the problem. Instead, the issue lies in the supporting or chaperoning cells that guide stem cells through normal development. Paterna’s work focuses on restoring that developmental process rather than replacing cells outright.

The conversation also explores how Paterna is developing approaches to help men with infertility at many different stages, offering options even when traditional treatments have failed. Dr. Jim Hotaling shares the deeply personal side of this work, reflecting on his role in delivering life altering news to families and how that responsibility drives his commitment to building better solutions.

This episode blends cutting edge science with the human reality behind infertility and why progress in this space matters so much.

In this episode of the Good Medicine Podcast, Dr. David Bearss sits down with Dr. Jim Hotaling and Dr. Brad Cairns from Paterna Biosciences to talk about a n...

This week on the Good Medicine Podcast, we are sharing a prerecorded panel hosted by Dr. David Bearss at the BioUtah Lif...
12/16/2025

This week on the Good Medicine Podcast, we are sharing a prerecorded panel hosted by Dr. David Bearss at the BioUtah Life Science Summit. The panel brings together leaders from across the industry, including Hariprasad Vankalapati of Biolexis, Alison O’Mahony of Seek Labs, and Ian Quigley of Leash Bio.

Together, they discuss how artificial intelligence is beginning to reshape drug discovery, diagnostics, and the way companies make decisions. The conversation highlights how AI helps teams understand both positive and negative data, identify emerging threats, and improve the success rate of bringing new drugs to market. This panel offers a grounded look at how AI is being used in real life science organizations today and what the future may hold.

This week on the Good Medicine Podcast, we are sharing a prerecorded panel hosted by Dr. David Bearss at the BioUtah Life Science Summit. The panel brings to...

This week on the Good Medicine Podcast, Dr. David Bearss speaks with Dr. Karson Kump of Aditum Bio, an organization focu...
12/09/2025

This week on the Good Medicine Podcast, Dr. David Bearss speaks with Dr. Karson Kump of Aditum Bio, an organization focused on advancing treatments for unmet medical needs by guiding programs through development with a disciplined, data-driven approach.

Dave opens the discussion by explaining how business development in life sciences is really about resource allocation. Scientists often follow what interests them, but companies must stay focused on what patients actually need and where the biggest gaps in medicine still exist.

Karson shares how spending enough time in science humbles you. He explains that good decisions come from yielding to the science and letting objective data lead the way. At the same time, choosing to take a program outside your own company and into the world of partnerships can feel risky, even though it may be the best path forward.

The conversation ends with Dave reflecting on ego, humility and delegation. In a field filled with smart, driven people, he has learned that real success comes from knowing when to step back and let someone who is better at a specific task take the lead.

This week on the Good Medicine Podcast, Dr. David Bearss speaks with Dr. Karson Kump of Aditum Bio, an organization focused on advancing treatments for unmet...

This week on the Good Medicine Podcast, Dr. David Bearss and Dr. Jeremiah Bearss explore what fat is actually communicat...
12/02/2025

This week on the Good Medicine Podcast, Dr. David Bearss and Dr. Jeremiah Bearss explore what fat is actually communicating to your brain and why the body often fights against weight loss.

Jeremiah explains how the body is wired to hold onto fat as a survival mechanism. Fat storage has always been the backup plan for famine, injury, and cold, which means the body’s default mode is to protect those reserves in case something goes wrong.

Dave discusses how inflammation influences this process. When the body is inflamed, fat can send signals to the brain that increase appetite and encourage the body to store even more fat. Reducing inflammation can help reverse that signal and make it easier to lose weight and keep it off.

They also talk about the many different GLP-1 targets currently being explored and why inflammation may be the reason these drugs work for so many people. Jeremiah explains how the next phase of drug development and health innovation will likely focus on shifting the course of the obesity crisis.

This week on the Good Medicine Podcast, Dr. David Bearss and Dr. Jeremiah Bearss explore what fat is actually communicating to your brain and why the body of...

Address

3900 N. Traverse Mountain Boulevard , Suite 200
Lehi, UT
84043

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Alerts

Be the first to know and let us send you an email when Biolexis Therapeutics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Biolexis Therapeutics:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram